Feb 23 (Reuters) - Cyclopharm:
- FY SALES REVENUE OF A$17.70 MILLION, UP 20.6%
- FINAL DIVIDEND MAINTAINED AT 0.5 AU CENTS PER SHARE
- REVENUE FROM TECHNEGAS GENERATOR & PAS SALES IS EXPECTED TO CONTINUE TO REBOUND TO PRE‐PANDEMIC LEVELS OR BEYOND IN 2022
Feb 23 (Reuters) - Cyclopharm: FY SALES REVENUE OF A$17.70...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.110(6.71%) |
Mkt cap ! $194.4M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.75 | $1.64 | $72.69K | 42.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4317 | $1.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 12891 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| CYC (ASX) Chart |